Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Blood (2016) 128 (22): 221.
Currently there are no citedby results. Try again later.
